malaria, falciparum
Showing 1 - 25 of 1,345
TES of Artemether-lumefantrine for Pf in Philippines in
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Malaria,Falciparum, Malaria, Vivax, Malaria Trial in Manokwari (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Malaria,Falciparum
- +5 more
- Dihydroartemisinin
- +3 more
-
Manokwari, West Papua, IndonesiaManokwari Regional General Hospital
Sep 11, 2023
TES of Artemether-lumefantrine for Pf in the Philippines in 2015
Completed
- Malaria,Falciparum
- Malaria Recrudescence
- (no location specified)
Jul 20, 2023
Malaria,Falciparum, Anemia in Children Trial (Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine pyrimethamine)
Not yet recruiting
- Malaria,Falciparum
- Anemia in Children
- Dihydroartemisinin-Piperaquine
- +3 more
- (no location specified)
Oct 9, 2023
Malaria,Falciparum, Anemia in Children Trial in Blantyre (Dihydroartemisinin-Piperaquine, Chloroquine, Sulfadoxine
Completed
- Malaria,Falciparum
- Anemia in Children
- Dihydroartemisinin-Piperaquine
- +2 more
-
Blantyre, MalawiKamuzu University of Health Sciences
Aug 4, 2023
Malaria,Falciparum Trial (Artemisia afra or Annua 10g oral infusion/tea per day for 14 days)
Not yet recruiting
- Malaria,Falciparum
- Artemisia afra or Annua 10g oral infusion/tea per day for 14 days
- (no location specified)
Mar 23, 2023
Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria Trial (ZY19489 + Ferroquine (FQ), Placebo)
Not yet recruiting
- Uncomplicated Malaria
- +2 more
- ZY19489 + Ferroquine (FQ)
- Placebo
- (no location specified)
Jun 18, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial (INE963, KAE609, SoC (Coartem))
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- INE963
- +3 more
- (no location specified)
Feb 17, 2023
Malaria, Malaria,Falciparum, Protozoan Infections Trial in Sheffield (Matrix M with RH5.1)
Recruiting
- Malaria
- +5 more
- Matrix M with RH5.1
-
Sheffield, United KingdomSheffield Teaching Hospitals, Royal Hallamshire Hospital
Nov 14, 2023
Malaria,Falciparum, Malaria Trial in Tambacounda (Dihydroartemisinin-piperaquine, Primaquine)
Active, not recruiting
- Malaria,Falciparum
- Malaria
-
Tambacounda, SenegalTambacounda Health District
Feb 1, 2023
Infections, Vector Borne Diseases, Systemic Inflammatory Response Syndrome Trial in Brisbane (MMV367, P. falciparum IBSM
Recruiting
- Infections
- +11 more
- MMV367
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Jul 30, 2023
Malaria, Malaria,Falciparum Trial in Ouagadougou (Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH
Not yet recruiting
- Malaria
- Malaria,Falciparum
- Seasonal Malaria Chemoprophylaxis (under 5 year old) implemented by the MoH without DOT
- +2 more
-
Ouagadougou, Burkina FasoGroupe de Recherche Action en Santé
May 18, 2023
Uncomplicated Plasmodium Falciparum Trial in Tambolaka (Dihydroartemisinin, Piperaquine, Primaquine)
Completed
- Uncomplicated Plasmodium Falciparum
- Dihydroartemisinin
- +3 more
-
Tambolaka, East Nusa Tenggara, IndonesiaKori Puskesmas
Apr 27, 2023
Plasmodium Vivax Among Duffy Negative Population in Cameroon.
Recruiting
- Malaria, Vivax
- +2 more
-
Dschang, West Region, CameroonDschang Health District
Nov 3, 2022
Malaria, Plasmodium Falciparum Trial in Oxford (Pfs48/45 in Matrix-M)
Recruiting
- Malaria
- Plasmodium Falciparum
- Pfs48/45 in Matrix-M
-
Oxford, United KingdomCCVTM, University of Oxford
Dec 13, 2022
Malaria,Falciparum, Malaria, Malaria Recrudescence Trial in Brisbane (Pyronaridine, P. falciparum IBSM infection)
Completed
- Malaria,Falciparum
- +5 more
- Pyronaridine
- P. falciparum IBSM infection
-
Brisbane, Queensland, Australia
- +1 more
Nov 3, 2022
Uncomplicated Plasmodium Falciparum Malaria Trial (Artemether-Lumefantrine-Amodiaquine (ALAQ), Artemether-Lumefantrine (AL),
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-Lumefantrine-Amodiaquine (ALAQ)
- +2 more
- (no location specified)
Jul 20, 2023
Uncomplicated Plasmodium Falciparum Malaria Trial in Bagamoyo (Artemether-lumefantrine and Amodiaquine Drug Combination,
Not yet recruiting
- Uncomplicated Plasmodium Falciparum Malaria
- Artemether-lumefantrine and Amodiaquine Drug Combination
- +2 more
-
Bagamoyo, Dar esSalaam, Tanzania
- +1 more
Feb 28, 2023
Diabetes and Metabolic Syndrome With Severe Malaria in Cameroon
Recruiting
- Diabetes Mellitus, Type 2
- +4 more
- diabetes
-
Dschang, West Cameroon, Cameroon
- +1 more
Jan 12, 2023
Malaria, Malaria,Falciparum, Parasitic Disease Trial in Oxford (RH5.1 and/or RH5.2-VLP with Matrix-M)
Not yet recruiting
- Malaria
- +4 more
- RH5.1 and/or RH5.2-VLP with Matrix-M
-
Oxford, Oxfordshire, United KingdomCentre for Clinical Vaccinology & Tropical Medicine (CCVTM)
Jul 27, 2023
Malaria, Malaria,Falciparum Trial in Baltimore (PfSPZ Vaccine, PfSPZ Challenge (7G8), Normal Saline)
Recruiting
- Malaria
- Malaria,Falciparum
- PfSPZ Vaccine
- +2 more
-
Baltimore, MarylandUniversity of Maryland, Baltimore, Center for Vaccine Developmen
Nov 2, 2022
Malaria,Falciparum Trial in Bamako (MSP3-CRM-Vac4All/ Alhydrogel®, Anti-Rabies Vaccine)
Not yet recruiting
- Malaria,Falciparum
- MSP3-CRM-Vac4All/ Alhydrogel®
- Anti-Rabies Vaccine
-
Bamako, MaliMalaria Research and Training Center (MRTC), University of Scien
Mar 7, 2023
Plasmodium Falciparum Malaria Trial in Bandarban, Lama (DHA/piperaquine and a SLD-PQ, Study vaccine R21/Matrix-M™)
Not yet recruiting
- Plasmodium Falciparum Malaria
- DHA/piperaquine and a SLD-PQ
- Study vaccine R21/Matrix-M™
-
Bāndarban, Bangladesh
- +1 more
Sep 28, 2023